Cigarette smoking and HIV/AIDS: Health implications, smoker characteristics and cessation strategies

AIDS Education and Prevention

Volumn 21, Issue SUPPL. 3, 2009, Pages 3-13

  Vidrine, Damon J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; BEHAVIOR; CIGARETTE SMOKING; CONFERENCE PAPER; DEMOGRAPHY; HEALTH HAZARD; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORBIDITY; MORTALITY; OUTPATIENT DEPARTMENT; PREVALENCE; PUBLIC HEALTH; SMOKING CESSATION; SOCIAL PSYCHOLOGY; VIROTHERAPY; HEALTH PROMOTION; HIGH RISK BEHAVIOR; METHODOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; RISK FACTOR; SMOKING;

HEALTH PROMOTION; HIV INFECTIONS; HUMANS; QUALITY OF LIFE; RISK FACTORS; RISK-TAKING; SMOKING; SMOKING CESSATION;

EID: 67650169868     PISSN: 08999546     EISSN: None     Source Type: Journal    
DOI: 10.1521/aeap.2009.21.3_supp.3     Document Type: Conference Paper

References (69)

1. American Medical Association, T. A. M. A. (1996). Health care needs of gay men and lesbians in the United States. Council on Scientific Affairs, American Medical Association. Journal of the American Medical Association, 275(17), 1354-1359.
2. American Medical Association. (1996). Health care needs of gay men and lesbians in the United States. Council on Scientific Affairs, American Medical Association. JAMA, 275(17), 1354-1359
3. American Cancer Society. (2007). Cancer facts and figures 2007. Atlanta, GA: Author.
4. Benard, A., Bonnet, F., Tessier, J. F., Fossoux, H., Dupon, M., Mercie, P., et al. (2007). Tobacco addiction and HIV infection: Toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care and STDs, 21(7), 458-468. (Pubitemid 47221641)
5. Bonnet, F., Lewden, C., May, T., Heripret, L., Jougla, E., Bevilacqua, S., et al. (2004). Malignancy- related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer, 101(2), 317-324. (Pubitemid 38890835)
6. Bozkurt, B. (2004). Cardiovascular toxicity with highly active antiretroviral therapy: Review of clinical studies. Cardiovascular Toxicology, 4(3), 243-260. (Pubitemid 39382987)
7. Breslau, N., & Johnson, E. O. (2000). Predicting smoking cessation and major depression in nicotine-dependent smokers. American Journal of Public Health, 90(7), 1122-1127. (Pubitemid 30445368)
8. Brockmeyer, N., Kreuter, A., Pfister, H., Altmeyer, P., & Wieland, U. (2007, February). Elevated anal HPV16 DNA loads in HIV+ men who smoke [abstract 872]. Paper presented at the 14th Conference on Retroviruses and Opportunistic Infections.
9. Burke, M., Furman, A., Hoffman, M., Marmor, S., Blum, A., & Yust, I. (2004). Lung cancer in patients with HIV infection: Is it AIDSrelated? HIV Medicine, 5(2), 110-114. (Pubitemid 38404665)
10. Burkhalter, J. E., Springer, C. M., Chhabra, R., Ostroff, J. S., & Rapkin, B. D. (2005). Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine and Tobacco Research, 7(4), 511-522. (Pubitemid 41600909)
11. Centers for Disease Control and Prevention. (2004). HIV/AIDS Surveillance Report, 2003. Atlanta, GA: US Department of Health and Human Services, Author.
12. Centers for Disease Control and Prevention. (2005). Annual smoking-attributable mortality, years of potential life lost, and productivity losses - United States, 1997-2001. Morbidity and Mortality Weekly Report, 54(25), 625-628.
13. Centers for Disease Control and Prevention. (2007a). Cigarette smoking among adults - United States, 2006. Morbidity and Mortality Weekly Report, 56(44), 1157-1161.
14. Centers for Disease Control and Prevention. (2007b). Racial/ethnic disparities in diagnoses of HIV/AIDS - 33 states, 2001-2005. Morbidity and Mortality Weekly Report, 56(9), 189-193.
15. Chattopadhyay, A., Caplan, D. J., Slade, G. D., Shugars, D. C., Tien, H. C., & Patton, L. L. (2005). Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults. Community Dentistry and Oral Epidemiology, 33(1), 35-44. (Pubitemid 41638657)
16. Clifford, G. M., Polesel, J., Rickenbach, M., Dal Maso, L., Keiser, O., Kofler, A., et al. (2005). Cancer risk in the Swiss HIV Cohort Study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Journal of the National Cancer Institute, 97(6), 425-432. (Pubitemid 40528605)
17. Collins, R. L., Kanouse, D. E., Gifford, A. L., Senterfitt, J. W., Schuster, M. A., McCaffrey, D. F., et al. (2001). Changes in health-promoting behavior following diagnosis with HIV: Prevalence and correlates in a national probability sample. Health Psychology, 20(5), 351-360. (Pubitemid 32843985)
18. Crothers, K., Griffith, T. A., McGinnis, K. A., Rodriguez-Barradas, M. C., Leaf, D. A., Weissman, S., et al. (2005). The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. Journal of General Internal Medicine, 20(12), 1142-1145. (Pubitemid 43110266)
19. Cummins, D., Trotter, G., Moussa, M., & Turham, G. (2005). Smoking cessation for clients who are HIV-positive. Nursing Standard, 20(12), 41-47.
20. Cunningham, W. E., Shapiro, M. F., Hays, R. D., Dixon, W. J., Visscher, B. R., George, W. L., et al. (1998). Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease. American Journal of Medicine, 104(2), 129-136. (Pubitemid 28117406)
21. Degenhardt, L., & Hall, W. (2001). The relationship between tobacco use, substance-use disorders and mental health: Results from the National Survey of Mental Health and Well-being. Nicotine and Tobacco Research, 3(3), 225-234. (Pubitemid 32821650)
22. Demopoulos, B. P., Vamvakas, E., Ehrlich, J. E., & Demopoulos, R. (2003). Non-acquired immunodeficiency syndrome-defining malignancies in patients infected with human immunodeficiency virus. Archives of Pathology and Laboratory Medicine, 127(5), 589-592. (Pubitemid 36534944)
23. Diaz, P. T., Wewers, M. D., Pacht, E., Drake, J., Nagaraja, H. N., & Clanton, T. L. (2003). Respiratory symptoms among HIVseropositive individuals. Chest, 123(6), 1977-1982.
24. Diaz, T., Chu, S. Y., Buehler, J. W., Boyd, D., Checko, P. J., Conti, L., et al. (1994). Socioeconomic differences among people with AIDS: Results from a Multistate Surveillance Project. American Journal of Preventative Medicine, 10(4), 217-222. (Pubitemid 24302884)
25. Elzi, L., Spoerl, D., Voggensperger, J., Nicca, D., Simcock, M., Bucher, H. C., et al. (2006). A smoking cessation programme in HIVinfected individuals: A pilot study. Antiviral Therapy, 11(6), 787-795. (Pubitemid 44497174)
26. Feldman, J. G., Minkoff, H., Schneider, M. F., Gange, S. J., Cohen, M., Watts, D. H., et al. (2006). The association of cigarette smoking with HIV prognosis among women in the HAART era - A report from the Women's Interagency HIV Study. American Journal of Public Health.
27. Furber, A. S., Maheswaran, R., Newell, J. N., & Carroll, C. (2007). Is smoking tobacco an independent risk factor for HIV infection and progression to AIDS? A systemic review. Sexual Transmitted Infections, 83(1), 41-46. (Pubitemid 46293804)
28. Gallagher, B., Wang, Z., Schymura, M. J., Kahn, A., & Fordyce, E. J. (2001). Cancer incidence in New York State acquired immunodeficiency syndrome patients. American Journal of Epidemiology, 154(6), 544-556. (Pubitemid 32867954)
29. Greenspan, D., Komaroff, E., Redford, M., Phelan, J. A., Navazesh, M., Alves, M. E., et al. (2000). Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS). Journal of Acquired Immune Defi- ciency Syndrome, 25(1), 44-50. (Pubitemid 30944971)
30. Greenwood, G. L., Paul, J. P., Pollack, L. M., Binson, D., Catania, J. A., Chang, J., et al. (2005). Tobacco use and cessation among a household-based sample of US urban men who have sex with men. American Journal of Public Health, 95(1), 145-151. (Pubitemid 40075897)
31. Gritz, E. R., Vidrine, D. J., Lazev, A. B., Amick, B. C., III, & Arduino, R. C. (2004). Smoking behavior in a low-income multiethnic HIV/ AIDS population. Nicotine and Tobacco Research, 6(1), 71-77. (Pubitemid 38372476)
32. Grulich, A. E. (2000). Update: Cancer risk in persons with HIV/AIDS in the era of combination antiretroviral therapy. AIDS Reader, 10(6), 341-346. (Pubitemid 30422803)
33. Haigentz, M., Jr. (2005). Aerodigestive cancers in HIV infection. Current Opinion in Oncology, 17(5), 474-478.
34. Hajjeh, R. A., Conn, L. A., Stephens, D. S., Baughman, W., Hamill, R., Graviss, E., et al. (1999). Cryptococcosis: Population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. Journal of Infectious Diseases, 179(2), 449-454. (Pubitemid 29086648)
35. Kirk, G. D., Merlo, C., P, O. D., Mehta, S. H., Galai, N., Vlahov, D., et al. (2007). HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clinical Infectious Diseases, 45(1), 103-110. (Pubitemid 46984625)
36. Lavole, A., Wislez, M., Antoine, M., Mayaud, C., Milleron, B., & Cadranel, J. (2006). Lung cancer, a new challenge in the HIV-infected population. Lung Cancer, 51(1), 1-11. (Pubitemid 43088620)
37. Lazev, A., Vidrine, D., Arduino, R., & Gritz, E. (2004). Increasing access to smoking cessation treatment in a low-income, HIVpositive population: The feasibility of using cellular telephones. Nicotine and Tobacco Research, 6(2), 281-286. (Pubitemid 38678857)
38. Lewden, C., Salmon, D., Morlat, P., Bevilacqua, S., Jougla, E., Bonnet, F., et al. (2005). Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: Emerging role of hepatitis and cancers, persistent role of AIDS. International Journal of Epidemiology, 34(1), 121-130. (Pubitemid 40347381)
39. Lloyd-Richardson, E. E., Stanton, C. A., Papandonatos, G. D., Betancourt, R. M., Stein, M., Tashima, K., et al. (2008). HIV-positive smokers considering quitting: Differences by race/ethnicity. American Journal of Health and Behavior, 32(1), 3-15.
40. Lloyd-Smith, E., Brodkin, E., Wood, E., Kerr, T., Tyndall, M. W., Montaner, J. S., et al. (2006). Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia. AIDS, 20(3), 445-450.
41. Lohse, N., Hansen, A. B., Pedersen, G., Kronborg, G., Gerstoft, J., Sorensen, H. T., et al. (2007). Survival of persons with and without HIV infection in Denmark, 1995-2005. Annals of Internal Medicine, 146(2), 87-95. (Pubitemid 351640011)
42. Mamary, E. M., Bahrs, D., & Martinez, S. (2002). Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care and STDs, 16(1), 39-42. (Pubitemid 34118921)
43. Metersky, M. L., Colt, H. G., Olson, L. K., & Shanks, T. G. (1995). AIDS-related spontaneous pneumothorax. Risk factors and treatment. Chest, 108(4), 946-951.
44. Mondy, K., & Tebas, P. (2007). Cardiovascular risks of antiretroviral therapies. Annual Review of Medicine, 58, 141-155.
45. Monforte, A., Abrams, D., Pradier, C., Weber, R., Bonnet, F., De Wit, S., et al. (2007, February). HIV-induced immunodeficiency and risk of fatal AIDS-defining and non-AIDSdefining malignancies: Results from the D:A:D Study [abstract 84]. Paper presented at the 14th Conference on Retroviruses and Opportunistic Infections.
46. Niaura, R., Shadel, W. G., Morrow, K., Tashima, K., Flanigan, T., & Abrams, D. B. (2000). Human immunodeficiency virus infection, AIDS, and smoking cessation: The time is now. Clinical Infectious Diseases, 31(3), 808-812. (Pubitemid 32295508)
47. Nuorti, J. P., Butler, J. C., Farley, M. M., Harrison, L. H., McGeer, A., Kolczak, M. S., et al. (2000). Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. New England Journal of Medicine, 342(10), 681-689.
48. Nuorti, J. P., Butler, J. C., Gelling, L., Kool, J. L., Reingold, A. L., & Vugia, D. J. (2000). Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Annals of Internal Medicine, 132(3), 182-190. (Pubitemid 30064917)
49. Palefsky, J. M., Minkoff, H., Kalish, L. A., Levine, A., Sacks, H. S., Garcia, P., et al. (1999). Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. Journal of the National Cancer Institute, 91(3), 226-236. (Pubitemid 29090991)
50. Palefsky, J. M., Shiboski, S., & Moss, A. (1994). Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men. Journal of Acquired Immune Deficiency Syndrome, 7(6), 599-606. (Pubitemid 24157669)
51. Palella, F. J., Jr., Baker, R. K., Moorman, A. C., Chmiel, J. S., Wood, K. C., Brooks, J. T., et al. (2006). Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV Outpatient Study. Journal of Acquired Immune Deficiency Syndrome,
52. Palella, F. J., Jr., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine, 338(13), 853-860.
53. Powles, T., Powles, J., Nelson, M., Sandison, A., Peston, D., Buchannan, J., et al. (2004). Head and neck cancer in patients with hu man immunodeficiency virus-1 infection: Incidence, outcome and association with Epstein-Barr virus. Journal of Laryngology and Otology, 118(3), 207-212. (Pubitemid 38446278)
54. Reynolds, N.R., Neidig, J.L., & Wewers, M.E. (2004). Illness representation and smoking behavior: a focus group study of HIVpositive men. J Assoc Nurses AIDS Care, 15(4), 37-47. (Pubitemid 39091143)
55. Sackoff, J. E., Hanna, D. B., Pfeiffer, M. R., & Torian, L. V. (2006). Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Annals of Internal Medicine, 145(6), 397-406. (Pubitemid 46768570)
56. Sax, P. E., & Kumar, P. (2004). Tolerability and safety of HIV protease inhibitors in adults. Journal of Acquired Immune Deficiency Syndrome, 37(1), 1111-1124. (Pubitemid 39166645)
57. Shiboski, C. H., Neuhaus, J. M., Greenspan, D., & Greenspan, J. S. (1999). Effect of receptive oral sex and smoking on the incidence of hairy leukoplakia in HIV-positive gay men. Journal of Acquired Immune Deficiency Syndrome, 21(3), 236-242. (Pubitemid 29331219)
58. Singh, B., Balwally, A. N., Shaha, A. R., Rosenfeld, R. M., Har-El, G., & Lucente, F. E. (1996). Upper aerodigestive tract squamous cell carcinoma. The human immunodeficiency virus connection. Archives of Otolaryngology - Head and Neck Surgery, 122(6), 639-643. (Pubitemid 26178796)
59. Slavinsky, J., III, Myers, T., Swoboda, R. K., Leigh, J. E., Hager, S., & Fidel, P. L., Jr. (2002). Th1/Th2 cytokine profiles in saliva of HIVpositive smokers with oropharyngeal candidiasis. Oral Microbiology and Immunology, 17(1), 38-43.
60. Spano, J. P., Massiani, M. A., Bentata, M., Rixe, O., Friard, S., Bossi, P., et al. (2004). Lung cancer in patients with HIV Infection and review of the literature. Medical Oncology, 21(2), 109-115. (Pubitemid 39108000)
61. Tirelli, U., Spina, M., Sandri, S., Serraino, D., Gobitti, C., Fasan, M., et al. (2000). Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors. Cancer, 88(3), 563-569.
62. Turner, J., Page-Shafer, K., Chin, D. P., Osmond, D., Mossar, M., Markstein, L., et al. (2001). adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care and STDs, 15(12), 615-624. (Pubitemid 34024420)
63. Vidrine, D. J., Arduino, R. C., & Gritz, E. R. (2006). Impact of a cell phone intervention on mediating mechanisms of smoking cessation in individuals living with HIV/AIDS. Nicotine and Tobacco Research, 8(supplement 1), S103-S108.
64. Vidrine, D. J., Arduino, R. C., & Gritz, E. R. (2007). The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS. AIDS Patient Care and STDs, 21(9), 659-666. (Pubitemid 47525389)
65. Vidrine, D. J., Arduino, R. C., Lazev, A. B., & Gritz, E. R. (2006). A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS, 20(2), 253-260.
66. Walensky, R. P., Paltiel, A. D., Losina, E., Mercincavage, L. M., Schackman, B. R., Sax, P. E., et al. (2006). The survival benefits of AIDS treatment in the United States. Journal of Infectious Diseases, 194(1), 11-19. (Pubitemid 43911920)
67. Webb, M. S., Vanable, P. A., Carey, M. P., & Blair, D. C. (2007). Cigarette smoking among HIV+ men and women: Examining health, substance use, and psychosocial correlates across the smoking spectrum. Journal of Behavior Medicine, 30(5), 371-383. (Pubitemid 47206603)
68. Wewers, M. E., Neidig, J. L., & Kihm, K. E. (2000). The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIVpositive smokers. Journal of the Association of Nurses in AIDS Care, 11(6), 37-44.
69. Zierler, S., Krieger, N., Tang, Y., Coady, W., Siegfried, E., DeMaria, A., et al. (2000). Economic deprivation and AIDS incidence in Massachusetts. American Journal of Public Health, 90(7), 1064-1073. (Pubitemid 30445360)